# Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling

> **NCT05606718** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 98 (estimated)

## Conditions studied

- Functional Mitral Regurgitation

## Interventions

- **DRUG:** Dapagliflozin
- **OTHER:** guideline-directed medical therapy (GDMT)

## Key facts

- **NCT ID:** NCT05606718
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05606718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05606718, "Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Remodeling". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05606718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*